(±)-Metoprolol (+)-tartrate salt
SIGMA/M5391 - ≥98% (titration), powder
Synonym: (±)
CAS Number: 56392-17-7
Empirical Formula (Hill Notation): C30H50N2O6 · C4H6O6
Molecular Weight: 684.81
EC Number: 260-148-9
MDL Number: MFCD00056257
Linear Formula: (C15H25NO3)2 · C4H6O6
Product Type: Chemical
| assay | ≥98% (titration) |
| color | white to off-white |
| form | powder |
| InChI | 1S/2C15H25NO3.C4H6O6/c2*1 |
| InChI key | YGULWPYYGQCFMP-CEAXSRTFSA |
| originator | Novartis |
| Quality Level | 200 ![]() |
| SMILES string | O[C@H]([C@@H](O)C(O)=O)C( |
| solubility | H2O: 50 mg/mL |
| Application: | (±)-Metoprolol (+)-tartrate salt has been used: • to modulate the immunological parameters in various studies • to study its effects onCa2+-calmodulin-dependent protein kinase II (CaMKII) activity in human and experimental heart failure (HF) • to examine the contribution of the adrenergic receptors to the production of norepinephrine (NE)-mediated O2- |
| Biochem/physiol Actions: | β1-adrenoceptor antagonist. |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Metoprolol has antihypertensive and anti-ischemic properties. It is used to treat arrhythmias. |
| Other Notes: | Shelf-life of the powder is at least 4 years. |
| Symbol | ![]() GHS08,GHS09 |
| Signal word | Warning |
| Hazard statements | H361d - H411 |
| Precautionary statements | P201 - P202 - P273 - P280 - P308 + P313 - P391 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (titration) |
| UNSPSC | 12352200 |



